Efficacy of Traditional Chinese Medicine Tonifying Kidney (Bushen) and Activating Blood (Huoxue) Prescription for Premature Ovarian Insufficiency: A Systematic Review and Meta-Analysis

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2020 May 9

PMID 32382277

Citations 13

Authors

Hui-Fang Li

Qi-Hong Shen

Wen-Jun Chen

Wei-Min Chen

Zhang-Feng Feng

Li-Ying Yu

Affiliations

Soon will be listed here.

Abstract

Objective: We carried out this systematic review and meta-analysis to evaluate the effectiveness of TKABP on POI.

Methods: The following eight databases were searched from the establishment to September 30, 2019, for randomized controlled trials (RCTs): PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), the Chinese BioMedical database (CBM), Chinese Scientific Journal Database (VIP), and the Wanfang database. The quality of evidence was estimated by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE).

Results: Twenty-three RCTs involving 1712 patients with POI were included. Compared to hormone therapy (HT) groups, TKABP groups showed a significantly higher total effective rate (RR: 1.10; 95% CI: 1.04-1.17; < 0.01, = 32%). In addition, TKABP groups revealed a better improvement in terms of serum follicle-stimulating hormone (FSH) levels, serum estradiol (E) levels, peak systolic velocity (PSV) of ovarian stromal blood, and Kupperman index (KI) score. However, serum luteinizing hormone (LH) levels and ovarian volume (OV) showed no significant statistical difference. Subgroup analyses showed that herbal paste and 3 months of treatment duration had a greater effect on the improvement of hormone levels. Besides, the occurrence of related adverse events in TKABP groups was lower than that in HT groups.

Conclusions: Our review suggests that TKABP appears to be an effective and safe measure for patients with POI, and the herbal paste may be superior. However, the methodological quality of included RCTs was unsatisfactory, and it is necessary to verify its effectiveness with furthermore standardized researches of rigorous design.

Citing Articles

Difference of the gut microbiota of premature ovarian insufficiency in two traditional Chinese syndromes.

Jiaman W, Yan N, Liya T, Fei M, Yanting L, Yuanyuan Z J Tradit Chin Med. 2025; 45(1):132-139.

PMID: 39957167 PMC: 11764924. DOI: 10.19852/j.cnki.jtcm.2025.01.012.

Efficacy and safety of HYYK formula for residual follicle revival in premature ovarian insufficiency: a multicenter, randomized, double-blind, placebo-controlled trial protocol.

Peng Y, Liu J, Li Y, Nie G, Cheng F, Feng D BMC Complement Med Ther. 2025; 25(1):46.

PMID: 39934764 PMC: 11817039. DOI: 10.1186/s12906-025-04803-3.

Network pharmacological analysis and experimental verification of Zisheng Tongmai decoction in the treatment of premature ovarian failure.

Wu J, Wen M, Wang Z, Yu K, Jin X, Liu C Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39352532 DOI: 10.1007/s00210-024-03476-y.

Exploring the Mechanism of Yiwei Decoction in the Intervention of a Premature Ovarian Insufficiency Rat Based on Network Pharmacology and the miRNA-mRNA Regulatory Network.

Fan W, Lei H, Li X, Zhao Y, Zhang Y, Li Y ACS Omega. 2024; 9(17):19009-19019.

PMID: 38708213 PMC: 11064180. DOI: 10.1021/acsomega.3c09551.

Dissecting the efficacy of the use of acupuncture and Chinese herbal medicine for the treatment of premature ovarian insufficiency (POI): A systematic review and metaanalysis.

Li H, Zhang J, Chen W Heliyon. 2023; 9(10):e20498.

PMID: 37818004 PMC: 10560776. DOI: 10.1016/j.heliyon.2023.e20498.

References

Ni Y, Xu D, Lv F, Wan Y, Fan G, Zou W . Prenatal ethanol exposure induces susceptibility to premature ovarian insufficiency. J Endocrinol. 2019; . DOI: 10.1530/JOE-19-0063. View

Zhang C, Ma K, Yuan B, Yuan Y, Chen Y . [Bushen Huoxue herbal medicine for treating hyperprolactinemia in women: a Meta-analysis]. Zhongguo Zhong Yao Za Zhi. 2019; 44(6):1087-1093. DOI: 10.19540/j.cnki.cjcmm.20190125.001. View

Podfigurna A, Meczekalski B . Cardiovascular health in patients with premature ovarian insufficiency. Management of long-term consequences. Prz Menopauzalny. 2018; 17(3):109-111. PMC: 6196783. DOI: 10.5114/pm.2018.78551. View

Jin Z, Huang X, Yang Y, Wang L, He D, Liu W . [Treatment of premature ovarian failure by bushen huoxue recipe combined estrogen and progesterone: a clinical research]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013; 33(5):586-9. View

Lim Y, Jeong K, Lee S, Chung H, Lee W . Association between premature ovarian insufficiency, early menopause, socioeconomic status in a nationally representative sample from Korea. Maturitas. 2019; 121:22-27. DOI: 10.1016/j.maturitas.2018.12.004. View

Chae-Kim J, Gavrilova-Jordan L . Premature Ovarian Insufficiency: Procreative Management and Preventive Strategies. Biomedicines. 2019; 7(1). PMC: 6466184. DOI: 10.3390/biomedicines7010002. View

Sharif K, Watad A, Bridgewood C, Kanduc D, Amital H, Shoenfeld Y . Insights into the autoimmune aspect of premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab. 2019; 33(6):101323. DOI: 10.1016/j.beem.2019.101323. View

Tao X, Zuo A, Wang J, Tao F . Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis. Climacteric. 2015; 19(1):27-36. DOI: 10.3109/13697137.2015.1094784. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009; 62(10):1006-12. DOI: 10.1016/j.jclinepi.2009.06.005. View

10.

Machura P, Grymowicz M, Rudnicka E, Pieta W, Calik-Ksepka A, Skorska J . Premature ovarian insufficiency - hormone replacement therapy and management of long-term consequences. Prz Menopauzalny. 2018; 17(3):135-138. PMC: 6196774. DOI: 10.5114/pm.2018.78559. View

11.

Whitcomb B, Purdue-Smithe A, Hankinson S, Manson J, Rosner B, Bertone-Johnson E . Menstrual Cycle Characteristics in Adolescence and Early Adulthood Are Associated With Risk of Early Natural Menopause. J Clin Endocrinol Metab. 2018; 103(10):3909-3918. PMC: 6179161. DOI: 10.1210/jc.2018-01110. View

12.

Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B . ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016; 31(5):926-37. DOI: 10.1093/humrep/dew027. View

13.

Shan J, Cheng W, Zhai D, Zhang D, Yao R, Bai L . Meta-Analysis of Chinese Traditional Medicine Bushen Huoxue Prescription for Endometriosis Treatment. Evid Based Complement Alternat Med. 2018; 2017:5416423. PMC: 5733233. DOI: 10.1155/2017/5416423. View

14.

Ma K, Wang K, Chen Y . [Infertility caused by salpingitis treated based on theory of kidney deficiency and blood stasis]. Zhongguo Zhong Yao Za Zhi. 2019; 44(6):1099-1103. DOI: 10.19540/j.cnki.cjcmm.20181225.004. View

15.

Podfigurna-Stopa A, Czyzyk A, Grymowicz M, Smolarczyk R, Katulski K, Czajkowski K . Premature ovarian insufficiency: the context of long-term effects. J Endocrinol Invest. 2016; 39(9):983-90. PMC: 4987394. DOI: 10.1007/s40618-016-0467-z. View

16.

Xu B, Li M, Luo Y . [Treatment of premature ovarian failure patients by bushen tiaojing recipe combined hormone replacement therapy: a clinical observation]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014; 33(10):1332-5. View

17.

Goh M, Nguyen H, Khan N, Milat F, Boyle J, Vincent A . Identifying and addressing osteoporosis knowledge gaps in women with premature ovarian insufficiency and early menopause: A mixed-methods study. Clin Endocrinol (Oxf). 2019; 91(4):498-507. DOI: 10.1111/cen.14049. View

18.

Zhao Y, Zheng H, Xu Y, Lin N . [Research progress in phytoestrogens of traditional Chinese medicine]. Zhongguo Zhong Yao Za Zhi. 2017; 42(18):3474-3487. DOI: 10.19540/j.cnki.cjcmm.2017.0135. View